Optical Genome Mapping in Hematological Malignancies
NCT05009537 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-08-17
Summary
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
Conditions
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-30
- Primary Completion
- 2022-09-30
- Completion
- 2026-09-30
Countries
- France
Study Locations
More Related Trials
-
Optical Genome Mapping in Characterization of Multiple Myeloma
NCT05786105 ·Status: COMPLETED
-
A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre
NCT05058937 ·Status: RECRUITING ·Phase: NA
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517 ·Status: RECRUITING
-
Genetic Exploration of the Molecular Basis of Malignancy in Adults
NCT02416518 ·Status: COMPLETED
-
Economic Evaluation of Innovative Molecular Analyses in Onco-haematology
NCT03750994 ·Status: UNKNOWN
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN
-
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
NCT00339963 ·Status: COMPLETED
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
NCT02664389 ·Status: TERMINATED ·Phase: NA
-
Molecular Disease Profile of Hematological Malignancies
NCT02459743 ·Status: UNKNOWN
-
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
NCT04060485 ·Status: UNKNOWN
-
Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases
NCT05848050 ·Status: COMPLETED ·Phase: NA
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.
NCT01079429 ·Status: TERMINATED
-
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
NCT02597179 ·Status: UNKNOWN
-
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
NCT05983172 ·Status: ENROLLING_BY_INVITATION
-
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
NCT05985941 ·Status: NOT_YET_RECRUITING
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
NCT05693974 ·Status: UNKNOWN
-
The Microbiome in Blood Cancer and HLH
NCT06734624 ·Status: NOT_YET_RECRUITING
-
Cost of Cancer Diagnosis Using Next-generation Sequencing Targeted Gene Panels in Routine Practice
NCT04656717 ·Status: COMPLETED
-
Genetic Analysis of Brain Tumors
NCT00031538 ·Status: TERMINATED
-
Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia
NCT01079507 ·Status: UNKNOWN
-
Cell-free Circulating DNA in Primary Cutaneous Lymphomas
NCT02883517 ·Status: COMPLETED